Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05611099 · ClinicalTrials.gov registry record · NA
Robustness and Usability of the Dreem 3 System for at Home Sleep Monitoring in an Insomnia Population.
A NA study, sponsored by Dreem.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05611099 is a NA study that has completed, run by Dreem. The registered enrollment target is 15 participants.
The verdict
NCT05611099, a NA study, has completed, sponsored by Dreem.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
There is an unmet medical need for monitoring sleep for multiple nights in a patient's home, without the inconvenience of traveling and staying overnight in a medical center, and without the need for a technician to set up a polysomnography (PSG) device at the patient's home. Several disorders, and particularly sleep disorders, are associated with insomnia symptoms, and longitudinal sleep assessment may support a better understanding and management of these patients, who currently seldom access sleep lab PSG. On one hand, this study aims at demonstrating whether the final device's user interface supports safe and effective use when being used at home over multiple nights. On the other, the study aims at confirming that stable and consistent data are measured in the device's actual use, for the records to be clinically usable in daily practice.
Interventions
- DEVICE Dreem 3 System vs WatchPAT One
- OTHER Usability Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2022-11-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05611099
The ClinicalTrials.gov registry entry for NCT05611099 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dreem, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dreem 3 System vs WatchPAT One is the first listed.
NCT05611099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05611099 about?
NCT05611099 is a clinical study titled "Robustness and Usability of the Dreem 3 System for at Home Sleep Monitoring in an Insomnia Population.". There is an unmet medical need for monitoring sleep for multiple nights in a patient's home, without the inconvenience of traveling and staying overnight in a medical center, and without the need for a technician to set up a polysomnography (PSG) device at the patient's home. Several disorders, and ...
What is the current status of trial NCT05611099?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-08-15. Estimated completion is 2022-11-05.
What interventions are being tested in trial NCT05611099?
The interventions under investigation include: Dreem 3 System vs WatchPAT One (DEVICE), Usability Questionnaire (OTHER).
Who is sponsoring clinical trial NCT05611099?
This trial is sponsored by Dreem, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.